Laporan laba rugi SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ · Healthcare · Biotechnology · Karyawan: 13 · CEO: Angelos Stergiou
- Harga
- $14,69 +2,0%
- Kapitalisasi pasar
- $2,78 M
- Nilai perusahaan
- $2,65 M Data per 2026-11-21
- Laporan terakhir
- Q3 '26 diajukan 2026-11-12
- Laporan berikutnya
- 2027-03-25 Estimasi EPS: -$0,05
Laporan laba rugi
| Laporan laba rugi | Tren | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Riset & pengembangan | $5,1 jt | $5,11 jt | $5,19 jt | $4,36 jt | $4,44 jt | $3,21 jt | $3,87 jt | $4,22 jt | $4,73 jt | $5,13 jt | $6,27 jt | $7,03 jt | |
| Umum & administrasi | $3,08 jt | $4,53 jt | $2,44 jt | $2,97 jt | $2,48 jt | $2,86 jt | $3 jt | $2,87 jt | $3,53 jt | $4,12 jt | $4,36 jt | $4,28 jt | |
| Beban operasional | $8,18 jt | $9,65 jt | $7,62 jt | $7,33 jt | $6,92 jt | $6,06 jt | $6,87 jt | $7,08 jt | $8,26 jt | $9,25 jt | $10,6 jt | $11,3 jt | |
| Laba operasional | -$8,18 jt | -$9,65 jt | -$7,62 jt | -$7,33 jt | -$6,92 jt | -$6,06 jt | -$6,87 jt | -$7,08 jt | -$8,26 jt | -$9,25 jt | -$10,6 jt | -$11,3 jt | |
| Pendapatan bunga | $41 rb | $79 rb | $151 rb | $221 rb | $181 rb | $250 rb | $272 rb | $292 rb | $597 rb | $845 rb | $1,02 jt | $1,22 jt | |
| Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...) | -$41 rb | -$79 rb | -$151 rb | -$221 rb | -$181 rb | -$250 rb | -$272 rb | -$292 rb | -$597 rb | -$845 rb | -$1,02 jt | -$1,22 jt | |
| Total pendapatan non-operasional | $41 rb | $79 rb | $151 rb | $221 rb | $181 rb | $250 rb | $272 rb | $292 rb | $597 rb | $845 rb | $1,02 jt | $1,22 jt | |
| Laba sebelum pajak | -$8,14 jt | -$9,57 jt | -$7,47 jt | -$7,11 jt | -$6,74 jt | -$5,81 jt | -$6,6 jt | -$6,79 jt | -$7,66 jt | -$8,41 jt | -$9,61 jt | -$10,1 jt | |
| Laba bersih | -$8,14 jt | -$9,57 jt | -$7,47 jt | -$7,11 jt | -$6,74 jt | -$5,81 jt | -$6,6 jt | -$6,79 jt | -$7,66 jt | -$8,41 jt | -$9,61 jt | -$10,1 jt | |
| EPS (dasar) | -$0,26 | -$0,21 | -$0,13 | -$0,10 | -$0,09 | -$0,07 | -$0,07 | -$0,06 | -$0,05 | -$0,05 | -$0,05 | -$0,05 | |
| EPS (dilusian) | -$0,26 | -$0,21 | -$0,13 | -$0,10 | -$0,09 | -$0,07 | -$0,07 | -$0,06 | -$0,05 | -$0,05 | -$0,05 | -$0,05 | |
| Saham (dasar, rata-rata tertimbang) | 30,8 jt | 44,8 jt | 57,5 jt | 68,3 jt | 74 jt | 87,8 jt | 94,3 jt | 108 jt | 153 jt | 172 jt | 189 jt | 202 jt | |
| Saham (dilusian, rata-rata tertimbang) | 30,8 jt | 44,8 jt | 57,6 jt | 68,3 jt | 74 jt | 87,8 jt | 98,6 jt | 108 jt | 153 jt | 172 jt | 189 jt | 202 jt | |
| Depresiasi & amortisasi | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $7,08 jt | $0 | $0 | $0 | $0 | |
| EBITDA | -$8,14 jt | -$9,57 jt | -$7,47 jt | -$7,11 jt | -$6,74 jt | -$5,81 jt | -$6,6 jt | $292 rb | -$7,66 jt | -$8,41 jt | -$9,61 jt | -$10,1 jt |
| Laporan laba rugi | Tren | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pendapatan | $0 | $0 | $0 | $0 | $1,9 jt | $7,6 jt | $1 jt | $0 | $0 | $0 | |
| Beban pokok pendapatan | $3 rb | $0 | $0 | $0 | $0 | $200 rb | $100 rb | $0 | $0 | $0 | |
| Laba kotor | -$3 rb | $0 | $0 | $0 | $1,9 jt | $7,4 jt | $900 rb | $0 | $0 | $0 | |
| Riset & pengembangan | $19,9 jt | $6,07 jt | $18,3 jt | $10,1 jt | $9,28 jt | $21,4 jt | $30,3 jt | $24 jt | $19,1 jt | $16 jt | |
| Umum & administrasi | $12 jt | $15,1 jt | $12,8 jt | $9,92 jt | $9,6 jt | $11,3 jt | $12,6 jt | $13,9 jt | $12,4 jt | $12,3 jt | |
| Beban operasional lainnya | $0 | $0 | -$3,03 jt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Beban operasional | $31,9 jt | $21,2 jt | $31,6 jt | $20 jt | $18,9 jt | $32,7 jt | $42,9 jt | $37,9 jt | $31,5 jt | $28,3 jt | |
| Laba operasional | -$16 jt | -$15,7 jt | -$31,6 jt | -$20 jt | -$17 jt | -$25,3 jt | -$42 jt | -$37,9 jt | -$31,5 jt | -$28,3 jt | |
| Pendapatan bunga | $0 | $0 | $0 | $118 rb | $26 rb | $6 rb | $317 rb | $525 rb | $632 rb | $1,41 jt | |
| Beban bunga | $3,51 jt | $462 rb | $266 rb | $118 rb | $0 | $0 | $0 | $0 | $0 | $0 | |
| Pendapatan non-operasional lainnya (keuntungan investasi, kurs ...) | $526 rb | $7,33 jt | -$2,81 jt | -$2,83 jt | -$208 rb | -$5,7 jt | -$10 jt | -$529 rb | -$632 rb | -$1,41 jt | |
| Total pendapatan non-operasional | $5,13 jt | -$7,79 jt | $2,54 jt | $668 rb | $208 rb | $4,36 jt | $649 rb | $529 rb | $632 rb | $1,41 jt | |
| Laba sebelum pajak | -$17,7 jt | -$23,5 jt | -$29 jt | -$19,4 jt | -$16,8 jt | -$20,9 jt | -$41,3 jt | -$37,3 jt | -$30,9 jt | -$26,9 jt | |
| Pajak penghasilan | $243 rb | $253 rb | -$1,38 jt | -$81 rb | -$17 rb | -$237 rb | $0 | $0 | $0 | $0 | |
| Laba bersih | -$23,5 jt | -$23,8 jt | -$27,7 jt | -$19,3 jt | -$16,8 jt | -$20,7 jt | -$41,3 jt | -$37,3 jt | -$30,9 jt | -$26,9 jt | |
| EPS (dasar) | -$933,13 | -$521,91 | -$157,72 | -$10,92 | -$2,11 | -$1,34 | -$2,13 | -$1,34 | -$0,50 | -$0,25 | |
| EPS (dilusian) | -$933,13 | -$521,91 | -$157,72 | -$10,92 | -$2,11 | -$1,34 | -$2,13 | -$1,34 | -$0,50 | -$0,25 | |
| Saham (dasar, rata-rata tertimbang) | 18 rb | 45 rb | 175 rb | 1,77 jt | 7,94 jt | 15,5 jt | 19,4 jt | 27,8 jt | 61,2 jt | 109 jt | |
| Saham (dilusian, rata-rata tertimbang) | 18,9 rb | 46,8 rb | 262 rb | 2,56 jt | 7,98 jt | 15,5 jt | 19,4 jt | 27,8 jt | 61,2 jt | 109 jt | |
| Depresiasi & amortisasi | $3 rb | $258 rb | $22 jt | $17,2 jt | $282 rb | $1,27 jt | $457 rb | $37,9 jt | $31,5 jt | $0 | |
| EBITDA | -$16 jt | -$22,8 jt | -$6,74 jt | $0 | -$16,5 jt | -$18,3 jt | -$31,5 jt | $529 rb | $632 rb | -$26,9 jt |
Distandardisasi dari laporan perusahaan; arus keluar dan biaya mempertahankan tanda yang dilaporkan penyedia. Arahkan kursor ke periode untuk melihat tanggal berakhirnya. Jumlah dalam USD.
Pendapatan, laba operasional, dan pertumbuhan
kuartalanMargin
kuartalanBiaya sebagai % pendapatan
kuartalanLaporan lainnya
Sumber
Laporan keuangan, pendapatan segmen, metrik, dan estimasi distandardisasi dari laporan perusahaan. Laba segmen dan setiap pos yang dilaporkan: SEC EDGAR (XBRL). Laporan yang dibaca: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data per 2026-11-21